文献速递冠心病外科

微创冠状动脉旁路移植术二十年经验

Minimally invasive coronary artery bypass: Twenty-year experience.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-12-29

该研究回顾性分析了1997至2016年1060例接受微创直接冠状动脉旁路移植术的患者,其中61%为孤立性左前降支近端病变,39%为多支病变。术后死亡率为0.8%,围术期卒中为0.3%,随访期内移植物通畅率为96.8%,长期生存率和无主要不良事件生存率良好。结论认为该技术安全、创伤小,远期效果满意。

要点

  • 微创直接冠状动脉旁路移植术术后死亡率低(0.8%),围术期卒中风险低(0.3%)。
  • 随访10年内移植物通畅率达96.8%,无因左胸廓内动脉-左前降支桥血管失败而再次手术。
  • 长期生存率5年87.1%、10年84.3%、15年79.8%,无主要不良事件生存率5年87.0%、15年70.5%。

核心结论

  • 微创直接冠状动脉旁路移植术可安全实施,术后死亡率和并发症率低,短期和长期生存率及无主要不良事件生存率优良,且减轻了手术创伤。

研究设计与样本

  • 回顾性队列研究,纳入1997年至2016年接受微创直接冠状动脉旁路移植术的1060例患者,其中646例(61%)为孤立性左前降支近端病变,414例(39%)为多支病变接受杂交冠状动脉血运重建或联合药物治疗。

主要发现

  • 患者平均年龄71±12.5岁,中位欧洲心脏手术风险评估系统II为3.2%(四分位距0.6%-7.8%)。
  • 术后死亡9例(0.8%),围术期卒中3例(0.3%)。
  • 随访10年内696例患者有血管造影或计算机断层扫描结果,移植物通畅率为96.8%。
  • 随访13.9±5.6年期间,无因左胸廓内动脉-左前降支桥血管失败而再次手术,但14例患者接受了左前降支或左胸廓内动脉-左前降支经皮冠状动脉介入治疗。
  • Kaplan-Meier生存曲线显示5年生存率87.1%(95%置信区间81-92.5),10年84.3%(95%置信区间77.1-91.4),15年79.8%(95%置信区间72.2-87.3);无主要不良事件生存率5年87.0%(95%置信区间85.9-88.1),15年70.5%(95%置信区间66.4-74.6)。

临床怎么用

  • 对于适合的冠心病患者,微创直接冠状动脉旁路移植术可作为减少手术创伤的外科血运重建选择,尤其适用于孤立性左前降支近端病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Minimally invasive direct coronary artery bypass for the left thoracic artery on the left anterior descending artery is a safe and less traumatic surgical technique. We retrospectively evaluated long-term outcomes in a large series of patients undergoing minimally invasive direct coronary artery bypass. METHODS: From 1997 to 2016, 1060 patients underwent minimally invasive direct coronary artery bypass: 646 patients (61%) with isolated proximal left anterior descending disease and 414 patients (39%) with multivessel disease as a part of hybrid coronary revascularization or in association with medical therapy. Long-term follow-up, major cardiac and cerebral adverse events, and freedom from angina were analyzed. RESULTS: Mean age of patients was 71 ± 12.5 years, and median European System for Cardiac Operative Risk Evaluation II was 3.2% (interquartile range, 0.6%-7.8%). Postoperative death occurred in 9 patients (0.8%), and perioperative stroke occurred in 3 patients (0.3%). An angiogram or computed tomography scan was performed and was available in patients within 10 years of follow-up (n = 696), demonstrating a 96.8% graft patency rate. At 13.9 ± 5.6 years of follow-up, no surgical reintervention was performed for left thoracic artery on left anterior descending artery graft failure, but 14 patients underwent left anterior descending or left thoracic artery on left anterior descending artery percutaneous coronary intervention. Kaplan-Meier survival curve shows 87.1% at 5 years (95% confidence interval, 81-92.5), 84.3% at 10 years (95% confidence interval, 77.1-91.4), and 79.8% at 15 years (95% confidence interval, 72.2-87.3). Survival freedom from major adverse events was 87.0% (95% confidence interval, 85.9-88.1) at 5 years and 70.5% (95% confidence interval, 66.4-74.6) at 15 years. CONCLUSIONS: Minimally invasive direct coronary artery bypass can be safely performed with low postoperative mortality and morbidity with excellent short- and long-term survival and freedom from major adverse events and angina with a reduced surgical invasiveness.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Repossini A, Di Bacco L, Nicoli F, et al. Minimally invasive coronary artery bypass: Twenty-year experience. J Thorac Cardiovasc Surg. 2018. PMID: 30739774. doi:10.1016/j.jtcvs.2018.11.149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。